YOKOHAMA, Japan--(BUSINESS WIRE)--CoreTissue BioEngineering Inc. (“CTBE”), a medical device start-up developing an artificial ligament derived from decellularized animal tissue, is the first company ...
Recognition as second most innovative smaller company across all industries highlights transformative impact on public health, impactful industry collaborations, and a novel manufacturing approach ...
SAN FRANCISCO--(BUSINESS WIRE)--Ossium Health, a bioengineering company leveraging stem cell science to develop treatments for diseases of the blood and immune systems, has been named as a winner of ...
Artificial intelligence is transforming biomedical science, accelerating research and revealing new tools for drug discovery and treatments for stubborn diseases. The University of Texas at Dallas has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results